We have collected information about Comprehensive Development Strategy Buccal Drug Delivery for you. Follow the links to find out details on Comprehensive Development Strategy Buccal Drug Delivery.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011081/
A Comprehensive Development Strategy in Buccal Drug Delivery. ... This work combines several methods in an integrated strategy to develop a matrix for buccal administration. For this purpose, tablets containing selected mucoadhesive polymers loaded with a model drug (omeprazole), free or in a complexed form with cyclodextrins, and in the ...Author: Ana Figueiras, Alberto A. C. C. Pais, Francisco J. B. Veiga
https://link.springer.com/article/10.1208/s12249-010-9546-1
Nov 30, 2010 · This work combines several methods in an integrated strategy to develop a matrix for buccal administration. For this purpose, tablets containing selected mucoadhesive polymers loaded with a model drug (omeprazole), free or in a complexed form with cyclodextrins, and in the absence and presence of alkali agents were subjected to a battery of tests.Author: Ana Figueiras, Alberto A. C. C. Pais, Francisco J. B. Veiga
https://www.researchgate.net/publication/49644390_A_Comprehensive_Development_Strategy_in_Buccal_Drug_Delivery
A Comprehensive Development Strategy in Buccal Drug Delivery Article (PDF Available) in AAPS PharmSciTech 11(4):1703-12 · December 2010 with 84 Reads How we measure 'reads'
https://www.ncbi.nlm.nih.gov/pubmed/21116750
A comprehensive development strategy in buccal drug delivery. Figueiras A(1), Pais AA, Veiga FJ. Author information: (1)CICS, Centro de Investigação em Ciências da Saúde, Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal. [email protected]: Ana Figueiras, Alberto A. C. C. Pais, Francisco J. B. Veiga
https://drug-dev.com/buccal-delivery-dissolvable-film-format-evolves-to-buccal-drug-delivery-applications/
Scott D. Barnhart is the Technical Director for ARx, LLC, a wholly owned subsidiary of Adhesives Research, Inc. With more than 25 years R&D experience, Mr. Barnhart’s career has focused on drug matrix formulation and process capabilities for transdermal drug delivery systems and the development of the company’s dissolvable film platform technologies.
https://core.ac.uk/display/8505908
Abstract. This work combines several methods in an integrated strategy to develop a matrix for buccal administration. For this purpose, tablets containing selected mucoadhesive polymers loaded with a model drug (omeprazole), free or in a complexed form with cyclodextrins, and in the absence and presence of alkali agents were subjected to a battery of tests.
https://www.researchgate.net/profile/Ana_Figueiras
Improvements in Topical Ocular Drug Delivery Systems: Hydrogels and Contact Lenses ... A Comprehensive Development Strategy in Buccal Drug Delivery. ... Join ResearchGate to …
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-018-0392-8
Sep 19, 2018 · The current review, presents an updated summary of recent advances in the field of nanomedicines and nano based drug delivery systems through comprehensive scrutiny of the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs (e.g., natural products) and selective diagnosis through disease marker ...Author: Jayanta Kumar Patra, Gitishree Das, Leonardo Fernandes Fraceto, Leonardo Fernandes Fraceto, Estefani...
https://tginnovations.wordpress.com/2014/05/07/buccal-drug-delivery-systems/
May 07, 2014 · The permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Drug delivery through various mucosal surfaces may improve bioavailability by bypassing the first-pass effects and avoiding the elimination of the drug within the gastrointestinal (GI) tract. Transmucosal drug delivery is being considered as an attractive…
https://drug-dev.com/company_profiles/nemera/
Nov 25, 2019 · Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health. NOW WITH END-TO-END DEVELOPMENT OFFERINGS
Searching for Comprehensive Development Strategy Buccal Drug Delivery?
You can just click the links above. The data is collected for you.
